Refine by
Prostate Antigen Suppliers Near Libya
20 companies found
based inPetah Tikva, ISRAEL
Isotopia Molecular Imaging was established in 2007 by renowned Israeli scientists and experts in the field of radio pharmaceuticals, and in collaboration with the International Metronotario investment organization. Advancing cancer diagnosis and ...
Prostate cancer is one of the leading causes of morbidity and mortality in men in the western world, and the second most common cancer in men worldwide. Imaging of the prostate-specific membrane ...
based inIrvine, CALIFORNIA (USA)
Established in 2011, Pathnostics is driven to pioneer a better future for physicians, patients, and the healthcare system with solutions that transform diagnostic and therapeutic dilemmas. Core capabilities in infectious disease and cancer ...
Prostate biopsies are performed when results from initial tests, like a prostate-specific antigen (PSA) blood test or digital rectal exam, indicate the possibility of prostate ...
based inEden Prairie, MINNESOTA (USA)
ProUroCare is engaged in the business of developing innovative products for the detection and characterization of prostate disease. Our initial product is a “prostate mechanical imaging” device called the ProUroScan System. The ProUroScan is an ...
ProUroScan is an advanced medical imaging system that uses an array of sensors mounted on a rectal probe, a central processing unit and software and image construction algorithms to provide a real time color image of abnormalities in the ...
based inKerrville, TEXAS (USA)
Vitanova Biomedical, Inc. (VNB) is a San Antonio, TX-based early stage biotechnology company developing patented (pending) technology licensed from the University of Texas at San Antonio. The company’s cancer treatment, Light-Activated Intracellular ...
Vitanova Biomedical’s Cancer Therapy Technology Platform is Called Light-Activated Intracellular Acidosis (LAIA). Vitanova Biomedical (VNB) has developed a proprietary energy-based technique to elicit cancer-specific intracellular acidosis. ...
based inTehran, IRAN
Pars Isotope Co is a prominent supplier and producer of radioisotopes in Iran, catering widely to the medical and industrial sectors. As the sole provider in the region, the company focuses on radiopharmaceuticals used for both the diagnosis and ...
The PARS-LUTOPSMA kit is an innovative theranostic radiopharmaceutical developed by Parsisotope Company, designed specifically for the treatment of metastatic prostate cancer. This kit is notable for being the first of its kind ...
based inBuford, GEORGIA (US) (USA)
Continuing To Do More To Save More Lives. Theragenics was founded in 1981 and quickly became a global leader in the manufacture of radioactive brachytherapy seeds for the treatment of localized prostate cancer. We began diversifying operations in ...
Brachytherapy seed placement is critical for prostate cancer outcomes. Cesium Blu (Cs-131) paired with the Sirius® MRI Marker gives you a clear picture of every implant for highly precise prostate cancer ...
based inBeverly, MASSACHUSETTS (USA)
Cellanyx is a growth stage emerging biotech advancing proprietary phenotypic (appearance and dynamics) biomarker tests based on Machine Vision and AI-driven analysis of live single tumor cells to improve risk-stratification and shared clinical ...
based inEdmonton, ALBERTA (CANADA)
Nanostics is a medical device and biotechnology company with a mission to provide clarity to people about their health by enabling better diagnosis and improving health care decisions through machine learning and extracellular vesicle detection. ...
Our lead product, ClarityDx Prostate® is designed to be a highly accurate test to assist in diagnosing clinically significant prostate cancer and improve prostate healthcare decisions. Validation of ClarityDX Prostate® is ongoing in a 2800 ...
based inBellaire, TEXAS (USA)
C4 Imaging develops innovative medical devices that enable clinicians to personalize patient care through accurate image-guided procedures. The company’s core proprietary technology, C4, is a unique magnetic resonance imaging (MRI) agent that has ...
“Permanent prostate brachytherapy dosimetry based only on MRI using positive contrast MRI markers [Sirius®] is feasible, accurate, and reduces the uncertainties arising from CT-MRI fusion abating the need for postimplant multimodality ...
based inMelbourne, AUSTRALIA
Starpharma Holdings Limited is a global biopharmaceutical company and a world leader in the development of new pharmaceutical and medical products based on proprietary polymers called dendrimers, with programs for COVID-19, DEP drug delivery and ...
DEP® cabazitaxel is an enhanced version of leading prostate cancer drug cabazitaxel (Jevtana®). Cabazitaxel (Jevtana®) had global sales of €536M in 2020 despite having multiple US FDA “Black Box” warnings. ...
based inGarching / Munich, GERMANY
ITM Isotope Technologies Munich SE is a privately owned biotechnology and radiopharmaceutical group of companies dedicated to the development, production and global supply of targeted diagnostic and therapeutic radiopharmaceuticals and radioisotopes ...
iQS-TS is a fully automated cassette-based Theranostics Synthesizer facilitating the routine preparation of radiolabeled ...
based inWaynesboro, VIRGINIA (USA)
Radium Incorporated was founded in 2004 by Cam Abernethy. Through his experience and direction, he has developed many patented (and patent pending) products that support Radium’s core product goals of increasing a worker’s quality of work, safety, ...
Designed to place a foley bag connected to a catheter attached to patients undergoing radiotherapy and scans using radiopharmaceuticals over performed by nuclear medicine specialists or radiologists. The see-through container reduces exposure to ...
based inOxford, UNITED KINGDOM
Blue Earth Diagnostics is an established molecular imaging company on a growth trajectory to provide innovative, well differentiated diagnostics solutions, informing patients and driving future therapies in cancer. Formed in 2014, Blue Earth ...
The targeting molecule delivers a therapeutic dose of radiation to kill tumour cells. Blue Earth Diagnostics acquired exclusive, worldwide rights to radiohybrid Prostate Specific Membrane Antigen (rhPSMA) targeted ...
based inWoodinville, WASHINGTON (USA)
Cancer Targeted Technology is designing and patenting small molecular weight enzyme inhibitors with unique and exceptional imaging and drug delivery properties. Cancer Targeted Technology (CTT) develops innovative targeted agents for cancer that ...
based inHayward, CALIFORNIA (USA)
BioAssay Systems develops and markets innovative and high-throughput assay solutions to satisfy the ever increasing demands of the life sciences industry. The founders of BioAssay Systems have over 50 years of extensive experience in modern drug ...
based inEl Cajon, CALIFORNIA (USA)
Calbiotech specializes in immunoassay development and manufacturing, with a comprehensive range of ELISA and CLIA assays for human and animal research, including specific assays for hormone, autoimmune disorders, cancer, infectious diseases and much ...
Catalog number: PS235T. Product type: ELISA. Quantity: 96 Tests (12x8 breakable strip wells). Standard range: 2-50 ng/ml. Analytical Sensitivity: 2 ng/ml. Sample volume: 25 µl/well. Species: Human. Storage and Stability: Product should be ...
based inWaltham, MASSACHUSETTS (USA)
Exosome Diagnostics, Inc. is commercializing minimally invasive molecular diagnostics in blood and urine to enable doctors to select optimal therapies for cancer and other diseases. Exosomes are lipid bilayer covered microvesicles shed by solid ...
The only exosome-based test that provides unique, actionable intelligence to help you decide if biopsy is necessary; independent of PSA and other standard of care (SOC) features. Connect with a representative in your area for more information ...
based inMonmouth Junction, NEW JERSEY (USA)
MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet ...
Dutasteride (GG745) is a potent inhibitor of both 5α-reductase isozymes. Dutasteride may possess off-target effects on the androgen receptor (AR) due to its structural similarity to ...
based inBerlin, GERMANY
Good diagnostic products require high-quality human biomaterials (serums, standards, control samples, purified proteins, and antibodies). Out of this need, we founded ourselves in 1997 as a spin-off of the research department of B.R.A.H.M.S. AG. ...
based in, CHINA
Mol Scientific provides customized peptide synthesis services including linear peptides, modified peptides, protein cross-linked peptides and more. Mol Scientific is a national high-tech enterprise, committed to providing high quality products and ...
![Mol Scientific - Model MPE0005599 - [-2] pPSA, Prostate-Specific Antigen, truncated peptide](https://d32zuqhgcrpxli.cloudfront.net/eyJidWNrZXQiOiJlZS1maWxlcyIsImtleSI6ImZpbGVzLzEyNzQ2MS9pbWFnZXMvMTI3NDYxXzBfMjAyMjA4MTYwNzQ1MDkxNjk5ODQ1XzQwMC5wbmciLCJlZGl0cyI6eyJyZXNpemUiOnsiZml0IjoiY29udGFpbiIsImJhY2tncm91bmQiOnsiciI6MjU1LCJnIjoyNTUsImIiOjI1NSwiYWxwaGEiOjF9LCJ3aWR0aCI6MTQzLCJoZWlnaHQiOjEwMn19fQ== "Mol Scientific - Model MPE0005599 - [-2] pPSA, Prostate-Specific Antigen, truncated peptide")
Mol Scientific offer high-quality [-2] pPSA, Prostate-Specific Antigen, truncated peptide product(MPE0005599). Mol Scientific committed to bring our esteemed customers high quality products and the finest services ...